Gluco-Chaser Inc. Company Profile

16:46 EDT 17th August 2018 | BioPortfolio

News Articles [0 Results]


Drugs and Medications [11 Associated Drugs and Medications listed on BioPortfolio]

Clarins sunscreen care milk- spf 50 plus [Laboratoires Clarins S.A.]

Clarins Sunscreen Care Milk-Lotion Spray SPF 50+

Tobramycin [Major Pharmaceuticals]


Tobramycin [Bausch & Lomb Incorporated]

TobramycinOphthalmic Solution USP, 0.3% (Sterile)

Tobramycin [Rebel Distributors Corp]

Tobramycin OphthalmicSolution USP, 0.3%

Tobramycin [Akorn, Inc.]

Tobramycin Ophthalmic Solution, USP0.3%–Sterile

PubMed Articles [10 Associated PubMed Articles listed on BioPortfolio]

R-High-CHOP/CHASER/LEED with Autologous Stem Cell Transplantation in Newly Diagnosed Mantle Cell Lymphoma: JCOG0406.

Although induction immunochemotherapy including high-dose cytarabine and rituximab followed by high-dose chemotherapy (HDC) with autologous stem cell transplantation (ASCT) is recommended for younger ...

Determination of affinity and residence time of potent drug-target complexes by label-free biosensing.

Prolonged drug-target occupancy has become increasingly important in lead optimization, and biophysical assays that measure residence time are in high demand. Here we report a practical label-free ass...

The Dynamic Effects of Isosteviol on Insulin Secretion and Its Inability to Counteract the Impaired β-Cell Function during Gluco-, Lipo-, and Aminoacidotoxicity: Studies In Vitro.

Isosteviol (ISV), a diterpene molecule, is an isomer of the backbone structure of a group of substances with proven antidiabetic capabilities. The aim of this study was to investigate if ISV elicits d...

Synthesis of New C- and N-β-d-Glucopyranosyl Derivatives of Imidazole, 1,2,3-Triazole and Tetrazole, and Their Evaluation as Inhibitors of Glycogen Phosphorylase.

The aim of the present study was to broaden the structure-activity relationships of- and-β-d-glucopyranosyl azole type inhibitors of glycogen phosphorylase. 1-Aryl-4-β-d-gluco-pyranosyl-1,2,3-triazo...

Akkermansia muciniphila can reduce the damage of gluco/lipotoxicity, oxidative stress, and inflammation and normalize intestine microbiota in streptozotocin-induced diabetic rats.

This study aimed to investigate how Akkermansia muciniphila can implicate type 2 diabetes mellitus and the mechanisms underlying the effects Akkermansia muciniphila on type 2 diabetes mellitus. Normal...

Clinical Trials [6 Associated Clinical Trials listed on BioPortfolio]

Evaluating the Feasibility of Using M-Health to Improve Serum Glucose Logs

Gestational diabetes mellitus (GDM) can cause adverse outcomes for the mother and fetus due to hyperglycemia. The purpose of this study is to evaluate the feasibility of improving pregnant...

Soluble Dietary Fibres in the Prevention of Type 2 Diabetes Mellitus

Controlling the glycemic impact of foodstuffs (by reducing the glycemic load of the diet by using soluble dietary fibres) may reduce the glycemic or insulinemic response. This may in turn ...

Growth Hormone (GH) in Congenital Adrenal Hyperplasia

Congenital adrenal hyperplasia (CAH) is a genetic rare disease, which alters the adrenal production of gluco and mineralo corticoids. The treatment consists in supplementing children using...

Adult Height Prediction in Congenital Adrenal Hyperplasia

Congenital Adrenal Hyperplasia (CAH) is a genetic rare disease, which alters the adrenal production of gluco and mineralo corticoïds. The treatment consists in supplementing children with...

Function of Catecholamines in the Brain During Depression

This study will explore brain function related to depressive symptoms and will examine DNA for genes that may be involved in depressive disorders, particularly genes that regulate synthesi...

Companies [4 Associated Companies listed on BioPortfolio]

Gluco-Chaser Inc

Gluco-Chaser Inc.


Vmersion-Health, developer of Gluco-Share, is a California Limited Partnership founded in 2011. Vmersion-Health develops and publishes social media applications for health-related...


Founded in 2002, Innodia is located in Montreal, Canada and presently employs over 30 individuals, including 24 scientists.In September 2003, Innodia completed a US$10 million Series A financing. Inno...

More Information about "Gluco-Chaser Inc." on BioPortfolio

We have published hundreds of Gluco-Chaser Inc. news stories on BioPortfolio along with dozens of Gluco-Chaser Inc. Clinical Trials and PubMed Articles about Gluco-Chaser Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Gluco-Chaser Inc. Companies in our database. You can also find out about relevant Gluco-Chaser Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record